Ep44: Utilizing Virtual Reality for Digital Therapeutics

In this episode, we hear from Sammeli Liikkanen, Digital Medicines Director at Orion Corporation. Orion Pharma is a globally operating Finnish pharmaceutical company with core therapy areas of neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases. In this episode, we cover: How Orion approaches non-molecular innovation Solving misconceptions in digital medicine VR as a modality for DTx Patient experience using VR Approaches to evidence generation Commercializing stand alone DTx vs Drug+ Guest Links and Resources: Connect with Sammeli Liikkanen on LinkedIn Visit https://www.orion.fi/en/ Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram